A Study to Assess Pharmacokinetics, Safety and Tolerability of Multiple Doses of CAT-354 in Subjects With Moderate Asthma

Stopped Study recruitment was terminated before the planned number of subjects was enrolled in CAT-354 10 mg/kg group due to the slow recruitment rate.

Conditions

• Moderate Asthma

Interventions

• BIOLOGICAL: CAT-354 1mg/kg
• BIOLOGICAL: CAT-354 5 mg/kg
• BIOLOGICAL: CAT-354 10mg/kg
• OTHER: Placebo

Sponsor

MedImmune LLC